Graft infection imaging with FDG and FDG-labeled leukocytes

Internal Medicine

Volumn 52, Issue 9, 2013, Pages 1009-1010

  Yilmaz, Sabire ^a   Asa, Sertac ^a   Ozhan, Meftune ^a   Halac, Metin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

FDG; FDG labeled WBC; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; ECHOGRAPHY; GRAFT INFECTION; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; MASS; POSITRON EMISSION TOMOGRAPHY; ABDOMINAL AORTA; BLOOD VESSEL TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; FEMORAL ARTERY; MULTIMODAL IMAGING; NEUTROPHIL CHEMOTAXIS; RADIOGRAPHY; RETROPERITONEUM; SCINTISCANNING; SURGERY; SURGICAL INFECTION;

AGED; AORTA, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHEMOTAXIS, LEUKOCYTE; FEMORAL ARTERY; FLUORODEOXYGLUCOSE F18; HUMANS; LEUKOCYTES; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROPERITONEAL SPACE; SURGICAL WOUND INFECTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877093213     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.9040     Document Type: Article

References (1)

1. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-Dglucose as a potential in vitro agent for labeling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 19: 183-190, 1992.